CN103645310B - A kind of Macrodantin chemiluminescence detection kit - Google Patents
A kind of Macrodantin chemiluminescence detection kit Download PDFInfo
- Publication number
- CN103645310B CN103645310B CN201310578405.9A CN201310578405A CN103645310B CN 103645310 B CN103645310 B CN 103645310B CN 201310578405 A CN201310578405 A CN 201310578405A CN 103645310 B CN103645310 B CN 103645310B
- Authority
- CN
- China
- Prior art keywords
- furadantin
- solution
- horseradish peroxidase
- liquid
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- NXFQHRVNIOXGAQ-YCRREMRBSA-N nitrofurantoin Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)NC(=O)C1 NXFQHRVNIOXGAQ-YCRREMRBSA-N 0.000 title claims abstract description 128
- 238000002038 chemiluminescence detection Methods 0.000 title claims abstract description 18
- 229940090037 macrodantin Drugs 0.000 title claims abstract description 17
- 229960000564 nitrofurantoin Drugs 0.000 claims abstract description 113
- 239000007788 liquid Substances 0.000 claims abstract description 49
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims abstract description 40
- 239000000126 substance Substances 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 30
- 238000001514 detection method Methods 0.000 claims abstract description 23
- 238000005406 washing Methods 0.000 claims abstract description 20
- 230000002163 immunogen Effects 0.000 claims abstract description 18
- 239000000427 antigen Substances 0.000 claims abstract description 16
- 102000036639 antigens Human genes 0.000 claims abstract description 16
- 108091007433 antigens Proteins 0.000 claims abstract description 16
- 238000002360 preparation method Methods 0.000 claims abstract description 15
- 238000004020 luminiscence type Methods 0.000 claims abstract description 10
- 239000006210 lotion Substances 0.000 claims abstract description 9
- 239000013642 negative control Substances 0.000 claims abstract description 9
- 239000013558 reference substance Substances 0.000 claims abstract description 9
- 238000011587 new zealand white rabbit Methods 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims description 120
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 22
- 239000002953 phosphate buffered saline Substances 0.000 claims description 21
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 19
- 239000012530 fluid Substances 0.000 claims description 17
- 108010058846 Ovalbumin Proteins 0.000 claims description 16
- 238000013016 damping Methods 0.000 claims description 16
- 238000000502 dialysis Methods 0.000 claims description 16
- 229940092253 ovalbumin Drugs 0.000 claims description 16
- 238000002649 immunization Methods 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 238000004458 analytical method Methods 0.000 claims description 13
- 230000036039 immunity Effects 0.000 claims description 13
- 239000000523 sample Substances 0.000 claims description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 239000007853 buffer solution Substances 0.000 claims description 12
- 239000011780 sodium chloride Substances 0.000 claims description 12
- 239000000872 buffer Substances 0.000 claims description 10
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 9
- 239000002671 adjuvant Substances 0.000 claims description 9
- 239000000758 substrate Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 239000004793 Polystyrene Substances 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 8
- 238000004108 freeze drying Methods 0.000 claims description 8
- 238000007037 hydroformylation reaction Methods 0.000 claims description 8
- 239000011259 mixed solution Substances 0.000 claims description 8
- 229920002223 polystyrene Polymers 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 238000004321 preservation Methods 0.000 claims description 8
- -1 sodium tetraphenylborate Chemical compound 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- 238000011146 sterile filtration Methods 0.000 claims description 8
- 210000002700 urine Anatomy 0.000 claims description 8
- 238000012360 testing method Methods 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 238000005304 joining Methods 0.000 claims description 6
- 239000002504 physiological saline solution Substances 0.000 claims description 6
- 230000008878 coupling Effects 0.000 claims description 5
- 238000010168 coupling process Methods 0.000 claims description 5
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 4
- 241000872931 Myoporum sandwicense Species 0.000 claims description 4
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 4
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 4
- 229910021538 borax Inorganic materials 0.000 claims description 4
- 229940098773 bovine serum albumin Drugs 0.000 claims description 4
- 150000001718 carbodiimides Chemical class 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 4
- 238000005227 gel permeation chromatography Methods 0.000 claims description 4
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 239000008055 phosphate buffer solution Substances 0.000 claims description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 4
- 239000004328 sodium tetraborate Substances 0.000 claims description 4
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 238000005286 illumination Methods 0.000 claims description 3
- 230000003053 immunization Effects 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 239000012488 sample solution Substances 0.000 claims description 3
- 239000012086 standard solution Substances 0.000 claims description 3
- 235000010288 sodium nitrite Nutrition 0.000 claims 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims 1
- 239000003550 marker Substances 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000021615 conjugation Effects 0.000 abstract description 2
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000003000 nontoxic effect Effects 0.000 abstract description 2
- 239000002207 metabolite Substances 0.000 abstract 1
- 238000005516 engineering process Methods 0.000 description 8
- 238000002965 ELISA Methods 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 238000007705 chemical test Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000002796 luminescence method Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000003640 drug residue Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 108700022034 Opsonin Proteins Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000003859 hyphenated technique Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000003822 preparative gas chromatography Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
- G01N21/763—Bioluminescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plasma & Fusion (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Furadantin standard substance (ng/ml) | Luminous value |
0.1 | 550000 |
0.3 | 183000 |
0.9 | 60000 |
2.7 | 21000 |
8.1 | 5500 |
24.3 | 1800 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310578405.9A CN103645310B (en) | 2013-11-18 | 2013-11-18 | A kind of Macrodantin chemiluminescence detection kit |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310578405.9A CN103645310B (en) | 2013-11-18 | 2013-11-18 | A kind of Macrodantin chemiluminescence detection kit |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103645310A CN103645310A (en) | 2014-03-19 |
CN103645310B true CN103645310B (en) | 2016-06-01 |
Family
ID=50250561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310578405.9A Active CN103645310B (en) | 2013-11-18 | 2013-11-18 | A kind of Macrodantin chemiluminescence detection kit |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103645310B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104215765A (en) * | 2014-09-13 | 2014-12-17 | 佛山市质量计量监督检测中心 | Preparation of immunizing antigen and envelope antigen for detecting nitrofurantoin metabolites |
CN104849475A (en) * | 2015-05-02 | 2015-08-19 | 王贤俊 | Quantified detection method for luteinizing hormone (LH) |
CN104897909A (en) * | 2015-05-02 | 2015-09-09 | 王贤俊 | Luteinizing hormone (LH)chemiluminescence immunoassay quantitative determination kit |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101393212A (en) * | 2008-11-04 | 2009-03-25 | 山东大学 | Chemiluminescence ELISA detection kit of furadantin |
CN101597330A (en) * | 2009-06-26 | 2009-12-09 | 青岛康地恩药业有限公司 | The synthetic method of a kind of Ractopamine hydrochloride artificial antigen |
CN102565032A (en) * | 2010-12-15 | 2012-07-11 | 北京勤邦生物技术有限公司 | Magnetic granule chemiluminescence kit for detecting nitrofurantoin metabolite and application of magnetic granule chemiluminescence kit |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101307303B (en) * | 2007-05-16 | 2010-10-13 | 哈尔滨仁皇药业股份有限公司 | Kit for detecting clenobuterol hydrochloride residue and method for preparing same |
CN101368961B (en) * | 2008-04-02 | 2012-11-14 | 北京科美生物技术有限公司 | Chemical luminescence immune analysis quantitative measuring reagent kit for urine bladder cancer antigen and preparation method thereof |
CN101738473B (en) * | 2008-11-13 | 2013-06-05 | 威海威高生物科技有限公司 | Treponema pallidum antibody diagnostic kit and preparation method thereof |
CN101446589A (en) * | 2008-12-29 | 2009-06-03 | 山东大学 | Chemiluminescent enzyme-linked immunosorbent assay (CELISA) kit for detecting salbutamol |
CN102539414A (en) * | 2010-12-16 | 2012-07-04 | 北京勤邦生物技术有限公司 | Magnetic particle chemiluminescence kit for detecting nitrofurantion and application thereof |
-
2013
- 2013-11-18 CN CN201310578405.9A patent/CN103645310B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101393212A (en) * | 2008-11-04 | 2009-03-25 | 山东大学 | Chemiluminescence ELISA detection kit of furadantin |
CN101597330A (en) * | 2009-06-26 | 2009-12-09 | 青岛康地恩药业有限公司 | The synthetic method of a kind of Ractopamine hydrochloride artificial antigen |
CN102565032A (en) * | 2010-12-15 | 2012-07-11 | 北京勤邦生物技术有限公司 | Magnetic granule chemiluminescence kit for detecting nitrofurantoin metabolite and application of magnetic granule chemiluminescence kit |
Non-Patent Citations (3)
Title |
---|
Development of an enzyme-linked immunosorbent assay for the detection of nitrofurantoin metabolite,1-amino-hydantoin,in animal tissue;Wenxiao Jiang,et al.;《Food Control》;20120131;第23卷(第1期);第20-25页 * |
动物饲料中呋喃唑酮的酶联免疫吸附检测研究;张会彩 等;《"2008年京津冀畜牧兽医科技创新交流会暨新思想、新观点、新方法论坛"论文集》;20100312;第159-163页 * |
呋喃妥因残留代谢物人工抗原的合成与鉴定;宋宁宁 等;《中国动物传染病学报》;20121231;第20卷(第3期);第55-61页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103645310A (en) | 2014-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1206899A (en) | Specific binding assays utilizing analyte-cytolsin conjugates | |
AU2007257105B8 (en) | Elisa kit for detecting Sudan red and method thereof | |
CN106645692B (en) | Estriol homogeneous enzyme immunoassay detection reagent, preparation method and detection method | |
CN108508215A (en) | A kind of time-resolved fluoroimmunoassay chromatograph test strip and its preparation method and application of detection tetracycline medication | |
CN109298177A (en) | Time-resolved fluorescence immunoassay method based on Magneto separate | |
CN101776685B (en) | Enzyme linked immunosorbent assay kit for detecting trimethoprim medicament and application thereof | |
CN101571539A (en) | Elisa kit for detecting cephalo-type medicine and application thereof | |
CN101231291A (en) | Kit and method for quantitative determination of Fumonisin B1 content in food by ELISA detection technique | |
CN108535486A (en) | A kind of chloramphenicol immunofluorescence assay method based on europium label | |
CN101799469A (en) | Enzyme linked immunosorbent assay kit for detecting residual clenbuterol hydrochloride and a detection method thereof | |
CN103645310B (en) | A kind of Macrodantin chemiluminescence detection kit | |
CN102206270B (en) | Saxitoxin artificial antigen and anti-saxitoxin antibody, their preparation methods and application | |
CN102288765A (en) | Immunofluorescence chloramphenicol detecting method based on quantum dots and special kit | |
CN101871936A (en) | Rhodamine B ELISA detection method | |
CN110095596A (en) | Chemiluminescence based on Fe-MOFs-fluorescence double-bang firecracker answers immunosensor | |
CN102079789A (en) | Method for detecting maduramicin and special enzyme-linked immunoassay reagent kit thereof | |
CN101299045B (en) | Method for detecting florfenicol and florfenicol amine and special-purpose enzyme-linked immunologic reagent kit thereof | |
CN103421072A (en) | Dexamethasone semi-antigen, preparation method and applications thereof | |
CN108802393A (en) | A kind of test strips and its preparation method and application method of detection tetrahydro-cannabinolic acid | |
CN102288763A (en) | Immunofluorescence method and special kit for detecting ractopamine based on quantum dots | |
CN105399639A (en) | Tyramine artificial antigen and antibody, and preparation methods and application thereof | |
CN102565399B (en) | Method for detecting hydrocortisone and special enzyme-linked immunosorbent assay kit thereof | |
CN109298178A (en) | Cardiac myosin binding protein C(cMyBP-C based on immunomagnetic beads) time-resolved fluoroimmunoassay kit | |
CN102262157B (en) | Quantum dot-based method for immunofluorescence of clenbuterol hydrochloride and special kit thereby | |
CN101769919A (en) | Immuno-chromatography detection device and detection method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Shanpu Inventor after: Zhou Xiaoshuang Inventor after: Shen Chengrui Inventor after: Zhang Zhipeng Inventor after: Zhang Pengyi Inventor after: Li Xiumei Inventor after: Geng Yujing Inventor after: Li Quanwei Inventor after: Zhang Heping Inventor after: Gao Jinyong Inventor after: Li Zhiyan Inventor after: Li Shengli Inventor after: Liu Haiqiang Inventor before: Wang Shanpu Inventor before: Liu Panpan Inventor before: Wang Huihui Inventor before: Wang Yudong Inventor before: Wu Tingcai |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PP01 | Preservation of patent right |
Effective date of registration: 20160822 Granted publication date: 20160601 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20170116 Granted publication date: 20160601 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190111 Address after: 110000 Youth Street 173-2, Shenhe District, Shenyang City, Liaoning Province, 1-22-9 Co-patentee after: LUOYANG LAIPSON INFORMATION TECHNOLOGY CO., LTD. Patentee after: Liaoning Bairui Biotechnology Co., Ltd. Address before: 471000 West N3 Peony Avenue, Luolong Science Park, Luoyang City, Henan Province Patentee before: LUOYANG LAIPSON INFORMATION TECHNOLOGY CO., LTD. |
|
TR01 | Transfer of patent right |